Physician profile
Barry E Gordon
NPI 1821074048
$3,424.29
in general payments reported to CMS, 2019-2025
33 companies · $922 in 2025
The $922 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $170 · 2021: $645 · 2022: $354 · 2023: $439 · 2024: $644 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,004.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $305.00 | 2021-2024 | Aquabeam System |
| Endo USA, INC. | $281.69 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $271.87 | 2021-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $245.91 | 2019-2023 | Aveed, Xiaflex |
| Clarus Therapeutics INC. | $222.88 | 2021 | |
| Pfizer INC. | $218.01 | 2019-2025 | |
| Boston Scientific Corporation | $189.53 | 2019-2024 | Spaceoar Vue System - 10ml, Ams 700 |
| Sumitomo Pharma America, INC. | $182.77 | 2024-2025 | Gemtesa, Orgovyx |
| Edap Technomed INC | $167.94 | 2025 | |
| Neotract INC. | $150.10 | 2019-2020 | |
| Coloplast Corp | $143.03 | 2020-2025 | |
| Medtronic, INC. | $120.97 | 2024-2025 | Interstim |
| Abbvie INC. | $96.37 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $95.81 | 2024-2025 | Provenge |
| Urogen Pharma, INC. | $91.65 | 2022-2025 | Jelmyto |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $91.10 | 2023-2024 | Erleada, Akeega |
| 180 Medical, INC. | $88.30 | 2020-2023 | Gentlecath Glide |
| Laborie Medical Technologies Corp. | $56.00 | 2023 | |
| Progenics Pharmaceuticals, INC. | $55.85 | 2023-2024 | Pylarify |
| Myovant Sciences INC. | $47.89 | 2021 | |
| Olympus America INC. | $46.60 | 2024-2025 | Itind System |
| Verity Pharmaceuticals INC. | $46.50 | 2025 | Tlando |
| C. R. Bard, INC. & Subsidiaries | $31.60 | 2025 | Bard Urinary Drainage Bag |
| Myriad Genetic Laboratories, INC. | $24.51 | 2024 | Prolaris |
| Convatec INC. | $22.24 | 2023 | |
| Astellas Pharma US INC | $20.12 | 2021 | |
| Blue Earth Diagnostics | $17.88 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.03 | 2025 | Adstiladrin |
| Tolmar, INC. | $17.00 | 2024 | |
| Innovation Technologies INC | $15.45 | 2022 | |
| Acerus Pharmaceuticals Corporation | $14.40 | 2022 | |
| Accord Healthcare, INC. | $14.29 | 2025 | |
| Allergan, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.